EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Panose prevents acute-on-chronic liver failure by reducing bacterial infection in mice

Jiaxin Li, Shihao Xie, Meiling Chen, Changze Hong, Yuqi Chen, Fengyuan Lyu, Niexin Tang, Tianqi Chen, Lingyan Zhao, Weihao Zou, Hongjuan Peng, Jingna Bao and 4 more

Journal of Clinical Investigation · 2025-07-15 · 135 (14)

DOI: 10.1172/jci184653 ↗

At a glance

Journal article in Journal of Clinical Investigation, published online on 2025-06-03. Written by Jiaxin Li and 15 co-authors. Institution: Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guan…. Major MEDLINE topics: Acute-On-Chronic Liver Failure, Bacterial Infections, Bacillota, Gastrointestinal Microbiome. Cited 7 times so far (Crossref); 55 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIDDK NIH HHS, Natural Science Foundation of Guangdong Province of China, National Key R&D Program of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Acute-on-chronic liver failure (ACLF) is a leading cause of global liver-related mortality. Bacterial infection, especially in patients with decompensated cirrhosis, commonly triggers ACLF and is difficult to treat with antibiotics. Therefore, finding alternative strategies for preventing and managing bacterial infection is an urgent priority. Here, we observed that patients with bacterial infection and decompensated cirrhosis, as well as ACLF mice, exhibited lower fecal panose levels than uninfected controls. Megamonas funiformis , with 4α-glucanosyltransferase (4αGT) as a key enzyme for panose production, was identified as a potential panose producer. Animal experiments demonstrated that panose efficiently reduced liver injury and extended survival in ACLF mice by mitigating bacterial infection. Further results revealed that panose enhanced resistance to bacterial infection by inhibiting oxidative stress–induced gut barrier disruption, thereby limiting bacterial dissemination. Mechanistically, panose interacted with the solute carrier family 7 member 11 (SLC7A11, also known as xCT) protein to boost antioxidant glutathione levels in intestinal epithelial cells. These findings highlight panose’s potential in preventing bacterial infection, offering a valuable insight into mitigating ACLF progression.

Subjects

MeSH terms (MEDLINE)

Acute-On-Chronic Liver FailureBacterial InfectionsBacillotaGastrointestinal MicrobiomeGlucansLiver CirrhosisAdultAgedAnimalsFemaleHumansMaleMiceMiddle AgedCell LineCohort StudiesDisease Models, AnimalMice, Inbred C57BLOxidative StressSpecific Pathogen-Free OrganismsDisease ResistanceDisease ProgressionAmino Acid Transport System y+Intestinal Barrier Function

Author keywords

Bacterial infectionsHepatologyMetabolismMicrobiologyTight junctions

Substances

GlucanspanoseSLC7A11 protein, humanSlc7a11 protein, mouseAmino Acid Transport System y+

Authors and institutions

  • Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Pathogen Biology, Guangdong Provincial Key Laboratory of Tropical Diseases Research, School of Public Health, Southern Medical University, Guangzhou City, Guangdong Province, China.
  • Key Laboratory of Infectious Diseases Research in South China (Ministry of Education), Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Medicine, UCSD, La Jolla, San Diego, California, USA.

Funding

  • NIDDK NIH HHS
  • Natural Science Foundation of Guangdong Province of China
  • National Key R&D Program of China
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • National Institutes of Health grant

Cite

APA

Li, J., Xie, S., Chen, M., Hong, C., Chen, Y., Lyu, F., Tang, N., Chen, T., Zhao, L., Zou, W., Peng, H., Bao, J., Gu, P., Schnabl, B., Chen, J., & Chen, P. (2025). Panose prevents acute-on-chronic liver failure by reducing bacterial infection in mice. Journal of Clinical Investigation, 135(14). https://doi.org/10.1172/jci184653

Vancouver

Li J, Xie S, Chen M, Hong C, Chen Y, Lyu F, et al. Panose prevents acute-on-chronic liver failure by reducing bacterial infection in mice. Journal of Clinical Investigation. 2025;135(14). doi:10.1172/jci184653

BibTeX
@article{Li2025,
  author = {Li, Jiaxin and Xie, Shihao and Chen, Meiling and Hong, Changze and Chen, Yuqi and Lyu, Fengyuan and Tang, Niexin and Chen, Tianqi and Zhao, Lingyan and Zou, Weihao and Peng, Hongjuan and Bao, Jingna and Gu, Peng and Schnabl, Bernd and Chen, Jinjun and Chen, Peng},
  title = {Panose prevents acute-on-chronic liver failure by reducing bacterial infection in mice},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {14},
  doi = {10.1172/jci184653}
}
Start for free →